Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen

(2017) E. Quant et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small cell lung cancer.

(2017) D. Shipley et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized phase II study of weekly versus every 3 week ixabepilone plus bevacizumab (ixa/bev) versus paclitaxel plus bev (pac/bev) as first-line therapy for metastatic breast cancer (MBC): Final results.

(2017) H. S. Rugo et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiangiogenic (AG) Synergy with Ixabepilone (IXA): Translation of Preclinical Studies to the Clinical Setting.:

(2010) F. Lee et al.   CANCER RESEARCH

Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

(2010) Joseph A. Sparano et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

(2009) Stacy Moulder et al.   BREAST CANCER RESEARCH AND TREATMENT

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

(2009) Don S. Dizon et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

(2009) Koen De Geest et al.   JOURNAL OF CLINICAL ONCOLOGY

Preclinical discovery of ixabepilone, a highly active antineoplastic agent

(2008) Francis Y. F. Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Preclinical efficacy spectrum and pharmacokinetics of ixabepilone

(2008) Francis Y. F. Lee et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

(2008) Dorte Lisbet Nielsen et al.   CANCER TREATMENT REVIEWS

Phase I/II Study of Ixabepilone plus Capecitabine in Anthracycline–Pretreated/Resistant and Taxane-Resistant Metastatic Breast Cancer

(2008) Craig Bunnell et al.   Clinical Breast Cancer

Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies

(2008) R. J. Lechleider et al.   CLINICAL CANCER RESEARCH

Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models

(2008) F. Y.F. Lee et al.   CLINICAL CANCER RESEARCH

Bevacizumab in Non-Small Cell Lung Cancer

(2008) Francesco Di Costanzo et al.   DRUGS

Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors

(2008) E. Rivera et al.   ONCOLOGIST

Triple-negative/basal-like breast cancer: review

(2008) Emad A. Rakha et al.   PATHOLOGY